Peptide COAs
Mots C
56 public audits matching your filters. Scores are PeptIQ’s legitimacy model; missing panels lower thoroughness but aren’t automatically “bad” — open a report to see pass, fail, reported, and missing panels clearly.
Public certificates
Approved community and directory-linked COAs only.
- MOTS-C + MOTS-C 10mg
American Peptides · Sep 5, 2026 · Core panels 100% · 3/7 panels · 99.9% purity · Doc 92
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns80Solid - MOTS-C
Crush Research · Sep 5, 2026 · Core panels 100% · 5/7 panels · 99.83% purity · Doc 95
Document structure and test panels align with what we expect from authentic lab reports.
Consistent with a legitimate COA79Solid - MOTS-C
Crush Research · Sep 5, 2026 · Core panels 100% · 5/7 panels · 99.85% purity · Doc 95
Document structure and test panels align with what we expect from authentic lab reports.
Consistent with a legitimate COA79Solid - MOTS-c
Crush Research · Sep 5, 2026 · Core panels 100% · 5/7 panels · 99.91% purity · Doc 95
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns79Solid - MOTS-C
Crush Research · Sep 5, 2026 · Core panels 100% · 5/7 panels · 99.57% purity · Doc 92
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns79Solid - MOTS-C
Crush Research · Sep 5, 2026 · Core panels 100% · 5/7 panels · 99.93% purity · Doc 92
Document structure and test panels align with what we expect from authentic lab reports.
Consistent with a legitimate COA79Solid - MOTS-C
Crush Research · Sep 5, 2026 · Core panels 100% · 5/7 panels · 99.52% purity · Doc 92
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns79Solid - MOTS-C
Crush Research · Sep 5, 2026 · Core panels 100% · 5/7 panels · 99.73% purity · Doc 95
Document structure and test panels align with what we expect from authentic lab reports.
Consistent with a legitimate COA79Solid - MOTS-C
Crush Research · Sep 5, 2026 · Core panels 100% · 5/7 panels · 99.84% purity · Doc 92
Document structure and test panels align with what we expect from authentic lab reports.
Consistent with a legitimate COA79Solid - MOTS-c
American Peptide Research · Sep 5, 2026 · Core panels 100% · 2/7 panels · 99.28% purity · Doc 92
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns77Solid - MOTS-c (10mg) + MOTS-c
American Peptide Research · Sep 5, 2026 · Core panels 100% · 2/7 panels · Doc 72
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns77Solid - MOTS-c
American Peptide Research · Sep 5, 2026 · Core panels 100% · 1/7 panels · Doc 45
Missing panels or key metadata — not enough evidence to treat this as a full certificate.
Incomplete documentation77Solid - MOTS-c
American Peptide Research · Sep 5, 2026 · Core panels 100% · 2/7 panels · 99.28% purity · Doc 92
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns77Solid - MOTS-C
Blank Peptides · Sep 5, 2026 · Core panels 100% · 3/7 panels · 99.59% purity · Doc 72
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns76Solid - MOTS-C
Blank Peptides · Sep 5, 2026 · Core panels 100% · 3/7 panels · 99.61% purity · Doc 88
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns76Solid - MOTS-C
Blank Peptides · Sep 5, 2026 · Core panels 100% · 3/7 panels · 99.76% purity · Doc 92
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns76Solid - MOTS-C + MOTS-C 10mg
Blank Peptides · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.299% purity · Doc 88
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns76Solid - MOTS-C + MOTS-C 10mg
Blank Peptides · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.42% purity · Doc 88
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns76Solid - MOTS-C + MOTS-C 10mg
Blank Peptides · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.128% purity · Doc 88
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns76Solid - MOTS-C + MOTS-C 10mg
Blank Peptides · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.06% purity · Doc 88
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns76Solid - MOTS-c
Blank Peptides · Sep 5, 2026 · Core panels 100% · 1/7 panels · Doc 72
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns76Solid - MOTS-c
Blank Peptides · Sep 5, 2026 · Core panels 100% · 2/7 panels · 99.53% purity · Doc 92
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns76Solid - MOTS-C
Peptide Partners · Sep 5, 2026 · Core panels 100% · 1/7 panels · Doc 72
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns73Solid - MOTS-C
Peptide Partners · Sep 5, 2026 · Core panels 100% · 1/7 panels · Doc 72
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns73Solid - MOTS-C
Peptide Partners · Sep 5, 2026 · Core panels 100% · 2/7 panels · 99.987% purity · Doc 72
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns73Solid - MOTS-C
Peptide Partners · Sep 5, 2026 · Core panels 100% · 1/7 panels · Doc 45
Missing panels or key metadata — not enough evidence to treat this as a full certificate.
Incomplete documentation73Solid - MOTS-c
Peptide Partners · Sep 5, 2026 · Core panels 33% · 1/7 panels · Doc 45
Missing panels or key metadata — not enough evidence to treat this as a full certificate.
Incomplete documentation73Solid - MOTS-c
Peptide Partners · Sep 5, 2026 · Core panels 100% · 1/7 panels · Doc 92
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns73Solid - MOTS-c
Peptide Partners · Sep 5, 2026 · Core panels 100% · 1/7 panels · Doc 72
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns73Solid - MOTS-c
Peptide Partners · Sep 5, 2026 · Core panels 100% · 1/7 panels · Doc 72
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns73Solid - MOTS-c
Peptide Partners · Sep 5, 2026 · Core panels 100% · 5/7 panels · 99.964% purity · Doc 92
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns73Solid - MOTS-c
Peptide Partners · Sep 5, 2026 · Core panels 33% · 1/7 panels · Doc 72
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns73Solid - MOTS-c
Peptide Partners · Sep 5, 2026 · Core panels 33% · 1/7 panels · Doc 92
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns73Solid - MOTS-c
Peptide Partners · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.89% purity · Doc 72
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns73Solid - MOTS-c
Peptide Partners · Sep 5, 2026 · Core panels 100% · 1/7 panels · Doc 88
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns73Solid - MOTS-c
Peptide Partners · Sep 5, 2026 · Core panels 100% · 2/7 panels · 99.87% purity · Doc 88
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns73Solid - MOTS-C
Pepturion · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99% purity · Doc 15
Multiple signals on this document conflict with known lab formats or verification patterns.
Evidence suggests fabrication63Mixed signals - MOTS-C + MS 40
Pepturion · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99% purity · Doc 68
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns63Mixed signals - MOTS-C + Peptides
BioLongevity Labs · Sep 5, 2026 · Core panels 67% · 2/7 panels · Doc 45
Missing panels or key metadata — not enough evidence to treat this as a full certificate.
Incomplete documentation59Mixed signals - MOTS-c
BioLongevity Labs · Sep 5, 2026 · Core panels 33% · 1/7 panels · Doc 92
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns59Mixed signals - MOTS-c (human) + MOTS-c
BioLongevity Labs · Sep 5, 2026 · Core panels 67% · 3/7 panels · 99.5% purity · Doc 72
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns59Mixed signals - MOTS-c (human) + MOTS-c
BioLongevity Labs · Sep 5, 2026 · Core panels 67% · 3/7 panels · 99.5% purity · Doc 72
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns59Mixed signals - MOTS-C + MOTSc-C 40mg
Lumira · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.025% purity · Doc 72
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns58Mixed signals - MOTS-c
Lumira · Sep 5, 2026 · Core panels 100% · 4/7 panels · 98.7% purity · Doc 92
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns58Mixed signals - MOTS-c
Lumira · Sep 5, 2026 · Core panels 100% · 4/7 panels · 98% purity · Doc 92
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns58Mixed signals - motsc + MOTS-c
Lumira · Sep 5, 2026 · Core panels 67% · 2/7 panels · Doc 45
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns58Mixed signals - MOTS-c
Lumira · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.2% purity · Doc 92
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns58Mixed signals - MOTS-c + MOTS-c - 40MG
Lumira · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.5063% purity · Doc 72
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns58Mixed signals - MOTS-C
Amino Tech · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.591% purity · Doc 72
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns55Mixed signals - MOTS-C
Paramount Peptides · Sep 5, 2026 · Core panels 33% · 1/7 panels · 99.336% purity · Doc 72
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns47Concerning - MOTS-C
Brand not listed · Jul 28, 2026 · Core panels 0% · 0/7 panels
Missing panels or key metadata — not enough evidence to treat this as a full certificate.
Incomplete documentation45Doc score
Community-sourced
Help build the COA record
PeptIQ’s market snapshot comes from moderator-approved certificates and curated peptide brands and testing laboratories — not invented stats. Contribute a COA or claim your listing.
Community submissions are reviewed before they appear on public market pages. Private COA scans stay private until you share them.
Brand owners: claim or list your peptide brand, upload COAs tied to it in the app, then track trust scores on your public brand page and the COA market.
Upload a COA
Scan a certificate of analysis in the app. Public shares go through review before the market.
List / claim a peptide brand
Apply to list or claim your vendor profile. Listings stay unpublished until PeptIQ approves them.
Claim / list a testing laboratory
Third-party peptide testing labs (HPLC, endotoxin, etc.) can claim or request a directory presence.
See brand trust & reputation
Browse vendor trust scores and legitimacy from moderator-approved public COAs on the market.
PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.